Resultaten visas 1 - 10 / 81
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Referentgranskad
DOI
10.1093/annonc/mdt231
Kubicka, S.; Greil, R.; Andre, T.; Bennouna, J.; Sastre, J.; Van Cutsem, E.; von Moos, R.; Österlund...
Annals of oncology2013

Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy

Referentgranskad
Öppen tillgång
DOI
10.1136/bmjophth-2019-000390
Wirkkala, J.; Bloigu, R.; Hautala, N.M.
BMJ open ophthalmology2019

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naive retinal vein occlusion related macular edema

Referentgranskad
Öppen tillgång
DOI
10.2147/OPTH.S144688
Laine, Ilkka; Lindholm, Juha-Matti; Ylinen, Petteri; Tuuminen, Raimo
Clinical ophthalmology2017

Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration

Referentgranskad
Öppen tillgång
DOI
10.1186/s12886-021-02076-1
Kähkönen, Mikael; Tuuminen, Raimo; Aaltonen, Vesa
Bmc ophthalmology2021

ANTERIOR CHAMBER FLARE DURING BEVACIZUMAB TREATMENT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Referentgranskad
DOI
10.1097/IAE.0000000000001061
Hautamaki, Asta; Luoma, Arto; Immonen, Ilkka
Retina: the journal of retinal and vitreous diseases2016

Comment on "Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-Associated Liposomes": Topical Liposomal Bevacizumab Results in Negligible Retinal Concentrations

DOI
10.1002/smll.201805199
Urtti, Arto
Small2019

BEVACIZUMAB plus CHEMOTHERAPY BEYOND FIRST PROGRESSION IN METASTATIC COLORECTAL CANCER PATIENTS PREVIOUSLY TREATED WITH BEVACIZUMAB-BASED THERAPY: TML STUDY SUBGROUP FINDINGS

Andre, Thierry; Jose Maria, Vieitez; Bouche, Olivier; Bennouna, Jaafar; Sastre, Javier; Alonso-Ordun...
Annals of oncology2012

A phase 3 trial of bevacizumab in ovarian cancer

Referentgranskad
DOI
10.1056/NEJMoa1103799
Perren, T.J.; Swart, A.M.; Pfisterer, J.; Ledermann, J.A.; Pujade-Lauraine, E.; Kristensen, G.; Care...
New england journal of medicine2011

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Referentgranskad
Öppen tillgång
DOI
10.1016/j.annonc.2019.12.006
André, T.;Vernerey, D.;Im, S. A.;Bodoky, G.;Buzzoni, R.;Reingold, S.;Rivera, F.;McKendrick, J.;Schei...
Annals of oncology2020

RANDOMISED PHASE III STUDY OF BEVACIZUMAB plus CHEMOTHERAPY BEYOND PROGRESSION IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: TML STUDY KRAS SUBGROUP FINDINGS

Van Cutsem, Eric; Maria Vieitez, Jose; Bouche, Olivier; Osterlund, Pia; Bennouna, Jaafar; Andre, Thi...
Annals of oncology2012

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Referentgranskad
DOI
10.1093/annonc/mdt231
2013

Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy

Referentgranskad
Öppen tillgång
DOI
10.1136/bmjophth-2019-000390
2019

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naive retinal vein occlusion related macular edema

Referentgranskad
Öppen tillgång
DOI
10.2147/OPTH.S144688
2017

Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration

Referentgranskad
Öppen tillgång
DOI
10.1186/s12886-021-02076-1
2021

ANTERIOR CHAMBER FLARE DURING BEVACIZUMAB TREATMENT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Referentgranskad
DOI
10.1097/IAE.0000000000001061
2016

Comment on "Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-Associated Liposomes": Topical Liposomal Bevacizumab Results in Negligible Retinal Concentrations

DOI
10.1002/smll.201805199
2019

BEVACIZUMAB plus CHEMOTHERAPY BEYOND FIRST PROGRESSION IN METASTATIC COLORECTAL CANCER PATIENTS PREVIOUSLY TREATED WITH BEVACIZUMAB-BASED THERAPY: TML STUDY SUBGROUP FINDINGS

2012

A phase 3 trial of bevacizumab in ovarian cancer

Referentgranskad
DOI
10.1056/NEJMoa1103799
2011

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Referentgranskad
Öppen tillgång
DOI
10.1016/j.annonc.2019.12.006
2020

RANDOMISED PHASE III STUDY OF BEVACIZUMAB plus CHEMOTHERAPY BEYOND PROGRESSION IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: TML STUDY KRAS SUBGROUP FINDINGS

2012